TY - JOUR
T1 - A comparison of the risk of acute myocardial infarction in patients receiving hemodialysis and peritoneal dialysis
T2 - A population-based, propensity score-matched cohort study
AU - Sun, Chien Yao
AU - Li, Chung Yi
AU - Sung, Junne Ming
AU - Cheng, Ya Yun
AU - Wu, Jia Ling
AU - Kuo, Yi Ting
AU - Chang, Yu Tzu
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/8
Y1 - 2020/8
N2 - Background and aims: Acute myocardial infarction (AMI) remains the major cause of morbidity and mortality in the dialysis population. Traditional cardiovascular (CV) risk factors are unable to fully account for the high incidence of AMI in the dialysis population. In this study, we investigated whether dialysis modalities could be one of the uremia-specific risk factors for AMI. Methods: Using the National Health Insurance Research Database, we recruited all incident dialysis patients from the period January 1, 1998 to December 31, 2010. The propensity score matching method was applied to form the matched pairs of hemodialysis (HD) and peritoneal dialysis (PD) patients. Incidence rate (IR), cumulative incidence rate (CIR) and multivariable subdistribution hazards models were employed to compare the risk of AMI in the HD and PD groups. Results: Of the 86,215 incident dialysis patients, 5,513 matched pairs of HD and PD patients were identified. The HD patients had a higher IR of AMI than the PD patients (9.71 vs. 8.35 per 1000 patient-years, respectively, p = 0.01). The CIR was also higher in the HD patients than in the PD patients (0.09 vs. 0.05), especially 4 years after dialysis therapy was initiated (p = 0.04). In the subdistribution hazards models, HD was still significantly associated with a higher risk of developing AMI (adjusted hazard ratio:1.30, 95% confidence interval:1.02–1.65). The results remained unchanged in various stratifications as well as in the analysis of the unmatched cohorts. Conclusions: Compared to PD, HD was significantly associated with higher risk of developing AMI, especially after 4 years since dialysis was initiated. Prevention and routine surveillance programs for AMI should be individualized according to dialysis modalities and vintage.
AB - Background and aims: Acute myocardial infarction (AMI) remains the major cause of morbidity and mortality in the dialysis population. Traditional cardiovascular (CV) risk factors are unable to fully account for the high incidence of AMI in the dialysis population. In this study, we investigated whether dialysis modalities could be one of the uremia-specific risk factors for AMI. Methods: Using the National Health Insurance Research Database, we recruited all incident dialysis patients from the period January 1, 1998 to December 31, 2010. The propensity score matching method was applied to form the matched pairs of hemodialysis (HD) and peritoneal dialysis (PD) patients. Incidence rate (IR), cumulative incidence rate (CIR) and multivariable subdistribution hazards models were employed to compare the risk of AMI in the HD and PD groups. Results: Of the 86,215 incident dialysis patients, 5,513 matched pairs of HD and PD patients were identified. The HD patients had a higher IR of AMI than the PD patients (9.71 vs. 8.35 per 1000 patient-years, respectively, p = 0.01). The CIR was also higher in the HD patients than in the PD patients (0.09 vs. 0.05), especially 4 years after dialysis therapy was initiated (p = 0.04). In the subdistribution hazards models, HD was still significantly associated with a higher risk of developing AMI (adjusted hazard ratio:1.30, 95% confidence interval:1.02–1.65). The results remained unchanged in various stratifications as well as in the analysis of the unmatched cohorts. Conclusions: Compared to PD, HD was significantly associated with higher risk of developing AMI, especially after 4 years since dialysis was initiated. Prevention and routine surveillance programs for AMI should be individualized according to dialysis modalities and vintage.
UR - http://www.scopus.com/inward/record.url?scp=85086447082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086447082&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2020.05.010
DO - 10.1016/j.atherosclerosis.2020.05.010
M3 - Article
C2 - 32553484
AN - SCOPUS:85086447082
SN - 0021-9150
VL - 307
SP - 130
EP - 138
JO - Atherosclerosis
JF - Atherosclerosis
ER -